GpharmaBioRESEARCH PEPTIDE LAB
Catalogue
GpharmaBioTα15 mg · 3 mL · LYOLOT GPB-4551RUO

Purity

98.9%

Fill

5 mg

Vial

3 mL

Lot

GPB-4551

Immune · CAS 62304-98-7

Tα1

Thymosin Alpha-1

128.40per 5 mg · 3 mL vial · ex-VATRequest this lot’s COA

A 28-residue N-terminally acetylated peptide. The acetyl cap is verified by MS on every lot — an uncapped fraction is the usual defect.

Thymosin alpha-1 is acetylated at the N-terminus, and incomplete acetylation is the defect we screen hardest for. An uncapped fraction differs from the target by 42 Da, which is well inside the resolution of our instrument but easy to miss if nobody is looking for it. We deconvolve the full charge envelope on every lot and report the ratio explicitly. The sequence is also acidic enough that it tails badly on older columns, so this product is run exclusively on freshly qualified stationary phase.

Primary sequence

AcSerAspAlaAlaValAspThrSerSerGluIleThrThrLys… (28)

Physical data

Molecular formula
C₁₂₉H₂₁₅N₃₃O₅₅
Molecular weight
3108.28 g/mol
CAS number
62304-98-7
Appearance
White lyophilised cake
Solubility
Soluble in water to 5 mg/mL
Storage
Lyophilised: −20 °C, desiccated

Certificate of analysis

Lot GPB-4551
RP-HPLC purity98.9% area @ 214 nm
Identity (ESI-MS)3108.6 observed, deconvoluted
Des-acetyl fraction0.42%
Net peptide content77.3%
Water (Karl Fischer)4.1%
Bacterial endotoxin< 0.25 EU/mg (LAL)

Handling

  • Reconstitute immediately before use where possible.
  • Stable ~10 days at 2–8 °C in solution.
  • Do not freeze reconstituted material.

For laboratory research use only. Not for human or veterinary consumption, diagnostic or therapeutic use. Supplied to qualified researchers at institutional addresses.